Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients by Rocconi et al

Gynecol Oncol. 2008 Oct;111(1):159-60; author reply 160. doi: 10.1016/j.ygyno.2008.06.005. Epub 2008 Jul 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Female
  • Humans
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / pathology
  • Neutropenia / chemically induced*
  • Ovarian Neoplasms / blood*
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology